Arena Pharma`s Presence at United European Gastroenterology Week
18 Oct 2019 //
BIOSPACE
Arena Pharmaceuticals Presented New Phase 2 Data for Etrasimod and Olorinab
08 Mar 2019 //
PR NEWSWIRE
United Therapeutics pays $800M-plus to grab Arena’s PhIII PAH drug
16 Nov 2018 //
ENDPTS
Arena 3 for 3 as Crohn’s drug meets proof-of-concept test
25 Sep 2018 //
FIERCE BIOTECH
Arena Pharmaceuticals Ph 1 Clinical Data for Ralinepag in PAH at the ESC
29 Aug 2018 //
PR NEWSWIRE